Vaccination with short-term-cultured autologous pbmcs efficiently activated stlv-1-specific ctls in naturally stlv-1-infected japanese monkeys with impaired ctl responses

HIGHLIGHTS

• who: Atsuhiko Hasegawa et al. from the Dental University, Tokyo, Japan, Cancer Cell Biology Laboratory, Department of Cancer Biology, Clinical have published the article: Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses, in the Journal: (JOURNAL)
• what: Using Japanese monkeys naturally infected with simian T-cell leukemia/T-lymphotropic virus type1 (STLV-1) as a model the authors demonstrate that short-term-cultured autologous peripheral blood mononuclear cells (PBMCs) can serve as a therapeutic vaccine to activate such To . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.